Neuritic plaques, a pathological hallmark in Alzheimer’s disease
(AD) brains, comprise extracellular aggregates of amyloid-beta (Aβ)
peptide and degenerating neurites that accumulate autolysosomes. We found that,
in the brains of patients with AD and in AD mouse models, Aβ
plaque-associated Olig2- and NG2-expressing oligodendrocyte progenitor cells
(OPCs), but not astrocytes, microglia, or oligodendrocytes, exhibit a
senescence-like phenotype characterized by the upregulation of p21/CDKN1A,
p16/INK4/CDKN2A proteins, and senescence-associated β-galactosidase
activity. Molecular interrogation of the Aβ plaque environment revealed
elevated levels of transcripts encoding proteins involved in OPC function,
replicative senescence, and inflammation. Direct exposure of cultured OPCs to
aggregating Aβ triggered cell senescence. Senolytic treatment of AD mice
selectively removed senescent cells from the plaque environment, reduced
neuroinflammation, lessened Aβ load, and ameliorated cognitive deficits.
Our findings suggest a role for Aβ-induced OPC cell senescence in
neuroinflammation and cognitive deficits in AD, and a potential therapeutic
benefit of senolytic treatments.